EW - Edwards Lifesciences Corp Stock Price, Fair Value and News

62.39USD+2.69 (+4.51%)Market Closed

Market Summary

USD62.39+2.69

Market Closed

4.51%

EW Alerts

2 major insider sales recently.

EW Stock Price

View Fullscreen

EW RSI Chart

EW Valuation

Market Cap

37.6B

Price/Earnings (Trailing)

26.61

Price/Sales (Trailing)

6.12

EV/EBITDA

20.74

Price/Free Cashflow

138.53

EW Price/Sales (Trailing)

EW Profitability

EBT Margin

26.19%

Return on Equity

19.85%

Return on Assets

14.51%

Free Cashflow Yield

0.72%

EW Fundamentals

EW Revenue

Revenue (TTM)

6.1B

Rev. Growth (Yr)

9.5%

Rev. Growth (Qtr)

4.18%

EW Earnings

Earnings (TTM)

1.4B

Earnings Growth (Yr)

3.35%

Earnings Growth (Qtr)

-5.07%

Breaking Down EW Revenue

Last 7 days

-27.9%

Last 30 days

-31.9%

Last 90 days

-27.8%

Trailing 12 Months

-24.5%

How does EW drawdown profile look like?

EW Financial Health

Current Ratio

3.75

Debt/Equity

0.08

Debt/Cashflow

0.88

EW Investor Care

Buy Backs (1Y)

0.60%

Diluted EPS (TTM)

2.32

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	6.1B	0	0	0
2023	5.5B	5.7B	5.8B	6.0B
2022	5.4B	5.4B	5.4B	5.4B
2021	4.5B	4.9B	5.1B	5.2B
2020	4.5B	4.3B	4.4B	4.4B
2019	3.8B	4.0B	4.2B	4.3B
2018	3.4B	3.5B	3.6B	3.7B
2017	3.1B	3.2B	3.3B	3.4B
2016	2.6B	2.7B	2.9B	3.0B
2015	2.4B	2.4B	2.4B	2.5B
2014	2.1B	2.1B	2.2B	2.3B
2013	1.9B	2.0B	2.0B	2.0B
2012	1.7B	1.8B	1.8B	1.9B
2011	1.5B	1.6B	1.6B	1.7B
2010	1.3B	1.4B	1.4B	1.4B
2009	1.3B	1.3B	1.3B	1.3B
2008	0	0	0	1.2B

Get all data in R, Python etc through our Historical Stock Data APIs

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

CEO	Mr. Bernard J. Zovighian
WEBSITE	edwards.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	17300

Edwards Lifesciences Corp Frequently Asked Questions

What is the ticker symbol for Edwards Lifesciences Corp? What does EW stand for in stocks?

EW is the stock ticker symbol of Edwards Lifesciences Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Edwards Lifesciences Corp (EW)?

As of Fri Jul 26 2024, market cap of Edwards Lifesciences Corp is 37.6 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EW stock?

You can check EW's fair value in chart for subscribers.

Is Edwards Lifesciences Corp a good stock to buy?

The fair value guage provides a quick view whether EW is over valued or under valued. Whether Edwards Lifesciences Corp is cheap or expensive depends on the assumptions which impact Edwards Lifesciences Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EW.

What is Edwards Lifesciences Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, EW's PE ratio (Price to Earnings) is 26.61 and Price to Sales (PS) ratio is 6.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EW PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Edwards Lifesciences Corp's stock?

In the past 10 years, Edwards Lifesciences Corp has provided 0.295 (multiply by 100 for percentage) rate of return.